Article
GNAO1 mutation-related severe involuntary movements treated with gabapentin.
Brain & development - 1 Apr 2021
Akasaka Manami, Kamei Atsushi, Tanifuji Sachiko, Asami Maya, Ito Jun, Mizuma Kanako, Oyama Kotaro, Tokutomi Tomoharu, Yamamoto Kayono, Fukushima Akimune, Takenouchi Toshiki, Uehara Tomoko, Suzuki Hisato, Kosaki Kenjiro
Abstract excerpt
BACKGROUND: Mutations in GNAO1 typically result in neurodevelopmental disorders, including involuntary movements. They may be improved using calcium-channel modulators. CASE: The patient visited our hospital at age 2 years because of moderate global developmental delay. Her intermittent, generalized involuntary movements started at age 8 years. A de novo GNAO1 mutation, NM_020988.2:c.626G > A, (p.Arg209Cys), was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
